UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000061583 |
|---|---|
| Receipt number | R000070293 |
| Scientific Title | The Effect of Text Messages Tailored to Psychological Characteristics on Enhancing Intentions to Quit Smoking: A Web-Based Survey Study |
| Date of disclosure of the study information | 2026/05/15 |
| Last modified on | 2026/05/13 10:58:08 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The Effect of Text Messages Tailored to Psychological Characteristics on Enhancing Intentions to Quit Smoking: A Web-Based Survey Study
Acronym
A Preliminary Study on Text Messages Designed to Promote Smoking Cessation
Scientific Title
The Effect of Text Messages Tailored to Psychological Characteristics on Enhancing Intentions to Quit Smoking: A Web-Based Survey Study
Scientific Title:Acronym
A Preliminary Study on Text Messages Designed to Promote Smoking Cessation
Region
| Japan |
Condition
Condition
Not specified
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To examine changes in intention to quit smoking after presenting messages tailored to psychological characteristics.
To examine the acceptability of messages tailored to psychological characteristics, including their comprehensibility and persuasiveness.
Basic objectives2
Others
Basic objectives -Others
Smoking cessation intention
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
Smoking cessation intention
Key secondary outcomes
Message comprehensibility: Ease of understanding the presented message.
Message persuasiveness / acceptability: The extent to which the message is acceptable or convincing to the participant.
Intention to use smoking cessation treatment: Whether the participant intends to use smoking cessation treatment in the future.
Type-specific congruence
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
Presentation of text messages
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Aged 20 years or older
Current smokers, defined as individuals who have smoked within the past 7 days
Able to respond in Japanese
Provided informed consent to participate in this study
Key exclusion criteria
Aged under 20 years
Holders of medical qualifications, to avoid bias due to medical knowledge
Students enrolled in universities, vocational schools, or other institutions for obtaining medical qualifications, to avoid bias due to medical knowledge
Individuals who do not provide consent to participate in the study
Individuals otherwise deemed inappropriate for participation by the principal investigator
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Miyuki |
| Middle name | |
| Last name | Odawara |
Organization
National Cancer Center
Division name
Institute for Cancer Control Division of Behavioral Sciences
Zip code
104-0045
Address
5-1-1 Tsukiji Chuo-ku Tokyo
TEL
03-3547-5201
modawara@ncc.go.jp
Public contact
Name of contact person
| 1st name | Hikari |
| Middle name | |
| Last name | Nagao |
Organization
National Cancer Center
Division name
Institute for Cancer Control Division of Behavioral Sciences
Zip code
104-0045
Address
5-1-1 Tsukiji Chuo-ku Tokyo
TEL
03-3547-5201
Homepage URL
hnagao@ncc.go.jp
Sponsor or person
Institute
National Cancer Center
Institute
Department
Personal name
Funding Source
Organization
MEXT(Japan)
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Cancer Center Institutional Review Board
Address
5-1-1 Tsukiji Chuo-ku Tokyo
Tel
03-3542-2511
irst@ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 05 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 04 | Month | 30 | Day |
Date of IRB
| 2026 | Year | 05 | Month | 13 | Day |
Anticipated trial start date
| 2026 | Year | 05 | Month | 17 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 05 | Month | 15 | Day |
Last modified on
| 2026 | Year | 05 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070293
